Related Experiment Video
Updated: Mar 14, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
MicroRNA-338-3p inhibits glucocorticoid-induced osteoclast formation through RANKL targeting
1Department of Physical Therapy, Wuxi Tongren International Rehabilitation Hospital, Wuxi, Jiangsu, China.
Abstract:
The differentiation deficiencies of osteoclast precursors (pre-OCs) may contribute to osteoporosis. Research on osteoporosis has recently focused on microRNAs (miRNAs) that play crucial roles in pre-OC differentiation. In the current study, we aimed to analyze the expression and function of the glucocorticoid (GC)-associated miRNA-338-3p (miR-338-3p) in osteoclast formation. We found that dexamethasone induced osteoclast differentiation and inhibited miR-338-3p expression. Overexpression of an miR-338-3p mimic in osteoclast precursor cells attenuated GC-induced osteoclast formation and bone resorption, whereas inhibition of miR-338-3p reversed these effects. The expression of the nuclear factor κB ligand RANKL, a potential target gene of miR-338-3p, was inversely correlated with miR-338-3p expression in pre-OCs. Furthermore, we demonstrated that RANKL was directly regulated by miR-338-3p and re-introduction of RANKL reversed the inhibitory effects of miR-338-3p on osteoclast formation and bone resorption. Taken together, these findings demonstrate that miR-338-3p may play a significant role in GC-induced osteoclast differentiation and function by targeting RANKL in osteoclasts.
Insights
MicroRNA-338-3p (miR-338-3p) inhibits glucocorticoid-induced osteoclast formation. This microRNA targets RANKL, suggesting a role in osteoporosis by regulating osteoclast differentiation and bone resorption.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Osteoporosis is linked to impaired osteoclast precursor (pre-OC) differentiation.
- MicroRNAs (miRNAs) are critical regulators of pre-OC differentiation and are implicated in osteoporosis research.
- Glucocorticoids (GCs) influence bone metabolism, and their associated miRNAs are of recent interest.
Purpose of the Study:
- To investigate the expression and function of glucocorticoid-associated microRNA-338-3p (miR-338-3p) in osteoclast formation.
- To elucidate the role of miR-338-3p in glucocorticoid-induced osteoclast differentiation and bone resorption.
Main Methods:
- Analyzing miR-338-3p expression in response to dexamethasone (a GC) in pre-OCs.
- Using miR-338-3p mimics and inhibitors to assess effects on osteoclast differentiation and bone resorption.
- Investigating the regulatory relationship between miR-338-3p and RANKL (receptor activator of nuclear factor kappa-B ligand).
- Confirming RANKL as a direct target of miR-338-3p and assessing rescue experiments.
Main Results:
- Dexamethasone treatment inhibited miR-338-3p expression and promoted osteoclast differentiation.
- Overexpression of miR-338-3p attenuated GC-induced osteoclast formation and bone resorption.
- Inhibition of miR-338-3p reversed these effects.
- RANKL expression was inversely correlated with miR-338-3p levels and was identified as a direct target.
- Re-introducing RANKL reversed the inhibitory effects of miR-338-3p.
Conclusions:
- miR-338-3p plays a significant role in regulating glucocorticoid-induced osteoclast differentiation and function.
- The mechanism involves miR-338-3p targeting RANKL, thereby modulating osteoclast activity.
- These findings offer insights into potential therapeutic strategies for osteoporosis related to GC use.
Related Concept Videos
Osteoclasts in Bone Remodeling
MicroRNAs
MicroRNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
TGF - β Signaling Pathway

